Post-transplantation lymphoproliferative disorder with gastrointestinal involvement

被引:17
作者
Inayat, Faisal [1 ]
Ul Hassan, Ghias [2 ]
Tayyab, Ghias Un Nabi [2 ]
Saif, Muhammad Wasif [3 ]
机构
[1] Allama Iqbal Med Coll, Lahore, Pakistan
[2] Ameer Ud Din Med Coll, Lahore, Pakistan
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源
ANNALS OF GASTROENTEROLOGY | 2018年 / 31卷 / 02期
关键词
Post-transplantation lymphoproliferative disorder; gastrointestinal; intussusception; iron-deficiency anemia; awareness; treatment;
D O I
10.20524/aog.2018.0226
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Post-transplantation lymphoproliferative disorders (PTLDs) are lymphoid proliferations or lymphomas that are the second most common tumors in adult transplant recipients. Most cases of PTLD are attributed to Epstein-Barr virus, which induces B-cell proliferation and occurs in the setting of severe immunosuppression after solid organ or bone marrow transplantation. The disorder is seen in 1-3% of liver transplant recipients and has a variable presentation chronology. Herein, we chronicle a case of aggressive B-cell lymphoma (PTLD WHO class-3) presenting with isolated gastrointestinal involvement in an Epstein-Barr virus-negative patient with living-donor liver transplantation, 4 years after receiving the transplant. While typical symptoms may be elusive in the immunocompromised setting, clinicians should be vigilant for underlying PTLD with isolated gastrointestinal involvement. Prompt detection and characterization by endoscopic evaluation with biopsy should be particularly stressed in such patients.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 10 条
[1]   Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies [J].
Al-Mansour, Zeina ;
Nelson, Beverly P. ;
Evens, Andrew M. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (03) :173-183
[2]   Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas [J].
Caillard, S. ;
Lamy, F. X. ;
Quelen, C. ;
Dantal, J. ;
Lebranchu, Y. ;
Lang, P. ;
Velten, M. ;
Moulin, B. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) :682-693
[3]   Post-transplant lymphoproliferative disorder presented as small bowel intussusception in adult liver transplant patient [J].
Joo, Sun Hyung ;
Acun, Zeki ;
Stefanovic, Alexandra ;
Blieden, Clifford R. ;
Ikpatt, Offiong F. ;
Moon, Jang .
JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2012, 82 (01) :50-53
[4]   Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center [J].
Knight, Jason S. ;
Tsodikov, Alexander ;
Cibrik, Diane M. ;
Ross, Charles W. ;
Kaminski, Mark S. ;
Blayney, Douglas W. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3354-3362
[5]   Posttransplantation lymphoproliferative disorder: Endoscopic findings [J].
O'Connor, JA ;
Cogley, C ;
Burton, M ;
Lancaster-Weiss, K ;
Cordle, RA .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (04) :458-461
[6]   Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States [J].
Quinlan, Scott C. ;
Pfeiffer, Ruth M. ;
Morton, Lindsay M. ;
Engels, Eric A. .
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (02) :206-209
[7]   Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: Report of a case [J].
Shitrit, D ;
Shitrit, ABG ;
Dickman, R ;
Sahar, G ;
Saute, M ;
Kramer, MR .
DISEASES OF THE COLON & RECTUM, 2005, 48 (11) :2144-2147
[8]  
Siegel A, 2017, ACG CASE REP J, V4, DOI 10.14309/crj.2017.86
[9]   Prospective study of sequential reduction in immunosuppression, interferon alpha-2b, and chemotherapy for posttransplantation lymphoproliferative disorder [J].
Swinnen, Lode J. ;
LeBlanc, Michael ;
Grogan, Thomas M. ;
Gordon, Leo I. ;
Stiff, Patrick J. ;
Miller, Alan M. ;
Kasamon, Yvette ;
Miller, Thomas P. ;
Fisher, Richard I. .
TRANSPLANTATION, 2008, 86 (02) :215-222
[10]   Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial [J].
Trappe, Ralf U. ;
Dierickx, Daan ;
Zimmermann, Heiner ;
Morschhauser, Franck ;
Mollee, Peter ;
Zaucha, Jan M. ;
Dreyling, Martin H. ;
Duehrsen, Ulrich ;
Reinke, Petra ;
Verhoef, Gregor ;
Subklewe, Marion ;
Huettmann, Andreas ;
Tousseyn, Thomas ;
Salles, Gilles ;
Kliem, Volker ;
Hauser, Ingeborg A. ;
Tarella, Corrado ;
Van Den Neste, Eric ;
Gheysens, Olivier ;
Anagnostopoulos, Ioannis ;
Leblond, Veronique ;
Riess, Hanno ;
Choquet, Sylvain .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05) :536-+